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Introduction: At variance from office spirometry, telespirometry has not been tested as a tool
for improving the ability of general practitioners (GPs) to manage chronic airway diseases.
Methods: After adequate training, 937 Italian GPs agreed to perform telespirometry in
subjects attending their clinics who had risk factors, persistent respiratory symptoms, or
a previous diagnosis of asthma or COPD. Each subject performed at least three forced expira-
tory manoeuvres using a turbine spirometer. Traces were sent by telephone to a Telespirometry
Central Office, where they were interpreted by a pulmonary specialist, according to defined
criteria. The result was sent in real time to the GP to assist the management of the patient.
Results: During 2 years, 20,757 telespirometries were performed, with a mean of 22.2 25.2
examinations for each GP. 70% of the tests met the criteria for good or partial co-operation,
allowing spirometric abnormalities to be detected in more than 40% of the tracings. The rate
of telespirometries that could not be evaluated at all was reasonably low (9.2%). For a subset
of the telespirometries, a comparison between acceptability criteria for telespirometry and
those recommended for laboratory (ATS) or office spirometry showed that the majority ofrestricted grant from AstraZeneca, Italy.
50 995366; fax: þ39 050 580124.
ed.unipi.it (P.L. Paggiaro).
9 Elsevier Ltd. All rights reserved.
Telespirometry in general practice 1733telespirometries with good co-operation satisfied completely, or with minor deviations, the
ATS and Office criteria.
Conclusions: Telespirometry was well accepted by Italian GPs, who obtained acceptable
screening traces in a large percentage of subjects. Therefore it might be considered a useful
alternative to office spirometry in improving themanagement of chronic airway diseases by GPs.
ª 2009 Elsevier Ltd. All rights reserved.Introduction
Asthma and chronic obstructive pulmonary disease (COPD)
affect up to 10% of the general population.1,2 COPD, in
particular, is becoming ever more frequent, due to the
increasing age of the population and the persistence of the
main risk factors.3 These diseases are responsible for
a heavy socio-economic burden due to the direct and to
indirect costs including loss of productivity.4,5
Early diagnosis and correct management are essential in
order to reduce the burden of these diseases. In asthmatic
subjects, early diagnosis and prompt initiation of inhaled
corticosteroid treatment were associated with a better
long-term prognosis.6 A pre-clinical demonstration of
persistent airway obstruction can help to recognize COPD
early and can increase the possibility of halting the
progressive decline in pulmonary function by smoking
cessation.7 Appropriate management of these diseases
requires measurement of pulmonary function, which is
strongly related to the level of asthma control8 or to the
prognosis of COPD,9 as recommended by international
guidelines.10,11 Unfortunately, many patients with asthma
or COPD have never undergone spirometry prior to the first
evaluation by a pulmonary specialist, either as outpatients
or as inpatients at the time of a hospital admission for an
acute exacerbation.12 The reasons for the underuse of
spirometry, at least in some countries like Italy, are related
not only to the poor recognition of asthma and COPD in the
general practice, but also to inadequate implementation of
guidelines, and to some technical factors such as poor
access to pulmonary function laboratories, and the feeling
that spirometry is complex and difficult to perform.13 One
study reported that whereas pulmonary specialists use
spirometry to assess asthmatic patients, less than 50% of
GPs in the USA do so.14
Several attempts have been made to improve the use of
spirometry in general practice. Office spirometry has been
standardised and proposed as a screening method for the
early identification of subjects with asthma or COPD.15 In
some countries, widespread use of office spirometry
detected a high prevalence of airway obstruction in
subjects at risk with no or minimal symptoms.16e18 In Italy,
one study tried to assess whether office spirometry was
able to improve the management of asthma and COPD, with
inconsistent results.19 Telespirometry (i.e., spirometry with
simple equipment in a GP’s clinic then sending the results
by telephone to a central office where the data are pro-
cessed, analysed and interpreted, and referring the results
back to the GPs) has been used to monitor selected asth-
matic patients living a long distance from the hospital, or
COPD patients with some limitation to access to
a hospital.20,21 Until now no data have been reported on theuse of telespirometry in GP’s clinics for the screening of
asthma and COPD.
This paper reports the results of an Italian study on the
feasibility of telespirometry in general practice. The study,
named ‘‘Alliance’’ to denote the link between pulmonary
specialists and GPs in the management of airway obstruc-
tive diseases, involved a large number of GPs under the
supervision of selected pulmonary specialists. This initia-
tive aimed at improving the familiarity of GPs with
spirometry, and telespirometry was chosen as a tool
whereby GPs had some interaction with the pulmonary
specialist located in the central laboratory in which the
telespirometric data were analysed.
Subjects and methods
Study protocol
This was an observational study, involving a large sample of
GPs from all regions of Italy. Fifty-one pulmonary units
distributed throughout the country were asked to partici-
pate in the study. In each centre, a pulmonary specialist
was selected to provide the education to a group of 20 GPs
selected according to their willingness to perform
telespirometry.
A Steering Committee defined the study design and
identified the 51 pneumology units. Educational material on
asthma, COPD and spirometry was prepared for the first
teaching session. In each pulmonary unit, a 6-h educational
session was performed with the 20 selected GPs: the topics
were the diagnosis of asthma and COPD, the technique for
performing spirometry and telespirometry, and the
presentation of the study design.
The GPs could perform telespirometry in her/his general
practice, in any subjects. Furthermore each GP was asked
to select, from the general practice, subjects with known
or suspected chronic airway disease, and to record their
data on a case report form. The detailed selection criteria
and the results of this part of the study are reported in
a previous publication.22 Each GP was equipped with
a simple, portable pneumotachograph (Spirotel, MIR,
Roma, Italy) to measure the main indices derived from
a maximal forced expiratory manoeuvre, and to transmit
these data by telephone to a Telemedicine Central Office,
TCO (ITMS Telemedicina Italia, Genoa, Italy). After
obtaining by the patient an informed consent, GPs per-
formed simple spirometry (at least three blows in the Spi-
rotel). After that, GP sent by telephone all tracings to the
TCO. In real time, it was connected by telephone to the
operator of the TCO who commented on the quality of all
spirometric traces, and offered an interpretation of the
results of the single patient. Then, the report was sent by
Table 1 Criteria for acceptability of the telespirometry.
Good co-operation Two manoeuvres
acceptable and reproducible
Partial co-operation One or more
acceptable manoeuvres, without reproducibility
No co-operation, only FEV1 evaluable No acceptable
manoeuvres for FVC and no reproducibility,
only FEV1 evaluable
No co-operation at all No acceptable
manoeuvres for FEV1 or FVC and no reproducibility
1734 M. Bonavia et al.fax to the GP’s office. All procedure required no more than
10 min. Bronchodilator test was not recommended, in order
to make the procedure as simple as possible and not time-
consuming.
The criteria used to assess the acceptability of a single
expiratory manoeuvre were: time to peak flow <150 ms,
back extrapolation<5% FVC (or 150 ml), lack of cough during
expiration, expiratory time 3 s, and end-expiratory flow
<0.2 l/s. The criteria used to accept single telespirometric
tests are reported in Table 1. Reproducibility was defined as
a difference in FEV1 and in FVC between two manoeuvres of
less than 5% and less than 200 ml. Acceptability criteria were
scored from full co-operation to insufficient co-operation.
The result of the test was described according to the
criteria reported in Table 2.
According to the interpretation of the telespirometry,
GPs were asked to make a possible diagnosis for the indi-
vidual patient observed (controlled or uncontrolled asthma
or COPD), and to report on the case report form the type of
intervention made as a consequence of the diagnosis
(possible changes in the usual management, or beginning
a new pharmacological treatment). The results of this part
of the study are reported in a different manuscript
submitted for publication.22
The local pulmonary specialist provided periodic
educational sessions during and at the end of the study, in
order to reinforce the interest in the study and to improve
the performance of telespirometry.
Telespirometry
Spirotel is a small turbine spirometerwhich collects data from
the expiratory manoeuvre and enables the measurement of
FEV1, FVC and PEF. A preliminary evaluation of the technicalTable 2 Interpretation of the results of the telespirometry.
Normal telespirometry
Mild airway obstruction
Moderate airway obstruction
Severe airway obstruction
Very severe airway obstruction
Abnormal telespirometry, but not clear
airway obstruction
Suspected airway obstruction
Only FEV1: normal
Only FEV1: abnormalproperties of the Spirotel was made by comparing the results
obtained with this instrument in a sample of patients with
asthma or COPD with those of spirometry performed in labo-
ratory with a conventional spirometer (Biomedin, Padova,
Italy). The concordance between the results of the Spirotel
and the laboratory spirometer for FEV1, FVC and PEF was
excellent (data not shown).
Quality evaluation of telespirometry
Two of the authors (GA and PLP) conducted careful exami-
nation of all the spirometric traces performed up to June 2003
bytheGPsof twocentres (NZ 296telespirometriesdefinedas
good or partial co-operation). The results of each tele-
spirometry test were analysed according to the criteria used
for quality evaluation of laboratory spirometry (ATS recom-
mendation)23 and of office spirometry.15 The percentage of
the telespirometries which satisfied the acceptability criteria
of ATS or office spirometry was computed.
Statistical analysis
A descriptive analysis was performed, reporting data with
continuous distributions as number of observations, means
and standard deviations, and categorical data as absolute
and percent frequencies.
Results
Fifty-one pulmonary centres recruited 1076 GPs; 937 of
these performed at least one telespirometry test. The
study started in October 2002, and ended in October 2004.
During this period, the 937 GPs sent data from 20,757FEV1/FVC 70%, and FEV1 80% of predicted
FEV1/FVC< 70% and FEV1 80% of predicted
FEV1/FVC< 70% and FEV1 between 79 and 50% of predicted
FEV1/FVC< 70% and FEV1 between 49 and 30% of predicted
FEV1/FVC< 70% and FEV1< 30% of predicted
FEV1/FVC 70% and FEV1< 80% of predicted
FEV1/FVC 70% and FEV1 80% of predicted
but with abnormal flow-volume loop morphology
FEV1 80% of predicted
FEV1< 80% of predicted
Table 3 Results of the telespirometries, according to the
criteria of acceptability and interpretation reported in
Tables 1 and 2.
N %
Good and partial co-operation
Normal telespirometry 8081 38.9
Mild airway obstruction 925 4.5
Moderate airway obstruction 1968 9.5
Severe airway obstruction 936 4.5
Very severe
airway obstruction
154 0.7
Abnormal spirometry,
but not clear
airway obstruction
1754 8.5
Suspected airway obstruction 694 3.3
Only FEV1 evaluable
Normal FEV1 3370 16.2
Abnormal FEV1 962 4.6
Not evaluable 1913 9.2
Total telespirometries 20,757 100.0
Table 4 Acceptability, according to ATS criteria, of the
telespirometries that satisfied the criteria of good and
partial co-operation (see Table 1).
Telespirometry in general practice 1735telespirometric tests to the TCO, with a mean of
22.2 25.2 tests per GP (range: 1e451). The tests were
related to 17,910 subjects (10,597 males and 7313
females), with a mean age of 50.3 17.6 years. The time
course of the recruitment of the patients is reported in
Fig. 1. The majority of patients were recruited in the first
14 months of the study. In the first year of the study, 70%
percent of GPs performed more than 10 telespirometric
tests, and 50% of them more than 20 tests.
The results of all the telespirometric tests are reported
in Table 3. Traces from only 9.2% of the telespirometric
tests were considered not evaluable at all (when no single
acceptable FEV1 was measurable). More than 20% of the
tests allowed only the measurement of FEV1 (in these
cases, FVC was not measurable, mainly because the dura-
tion of expiration was shorter than 3 s). Thus, the criteria
defining good and partial co-operation were fulfilled by 70%
of the telespirometric tests.
Evidence of mild to severe airway obstruction was
observed in 19.2% of all the telespirometric tests, but in
27.4% of those tests with a good or acceptable co-opera-
tion. A small number of the tests were suggestive of airway
obstruction according to the shape of the flow-volume
curve (3.3% of all tests), while another consistent
percentage (8.5% of all tests) of the telespirometric trac-
ings showed some abnormalities (mainly a concomitant
reduction in FEV1 and FVC with normal FEV1/FVC ratio) not
clearly attributable to airway obstruction. Some abnor-
mality was found in 39.2% of all evaluable telespirometric
tests, and in 44.3% of those tests that fulfilled the accept-
ability criteria of good and partial co-operation.
A sample of 296 telespirometric tests which satisfied the
criteria of good and partial co-operation were analysed in
comparison to the ATS and Office quality criteria (Tables 4
and 5). Among the 296 tests, 34.5% completely satisfied all
ATS criteria for acceptability of the test (at least three
acceptable manoeuvres, expiratory duration >6 s, repro-
ducibility of FEV1 and FVC). In another 48.7% ATS criteria
were satisfied except for one criterion (sometimes two and
not three acceptable manoeuvres, sometimes a short expi-
ratory duration in one ormoremanoeuvres, sometimes a lack
of reproducibility of FVC measurements); in this group were
included telespirometries which do not satisfy ATS accept-
ability criteria only for the expiration time<6 s (24.3% of theNumber of GPs sending at least one telespirometry
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Figure 1 Number of GPs sending at least one telespirometry
(two-monthly description).full sample). Thepercentageof telespirometric tests thatdid
not satisfy more than one of ATS criteria was low (16.9%).
When considering acceptability according to Office criteria,
it was found that 62.5% of all the telespirometric tests
considered acceptable for good co-operation also satisfied
the main criteria (Aþ Bþ C) of office spirometry.
Discussion
The results of this study show that Italian GPs accept tel-
espirometry as an exploratory useful way of improving the
assessment of patients with suspected obstructive pulmo-
nary diseases, and that they are able to perform acceptableNo. %
Good and partial
co-operation (telespirometry
criteria)
296 100
All ATS criteria satisfied 102 34.5
Only two acceptable
manoeuvres satisfying the
ATS criteria
57 19.2
All ATS criteria
satisfied, except
expiratory time <6 s in one
or more manoeuvres
72 24.3
All ATS criteria
satisfied, except FVC
reproducibility
15 5.1
Two or more ATS criteria
not satisfied
50 16.9
Table 5 Acceptability, according to Office criteria, of the
telespirometries that satisfied the criteria of good and
partial co-operation (see Table 1).
No. %
Good and partial
co-operation (telespirometry
criteria)
296 100
Office A
(two acceptable
manoeuvres, and FEV1/FVC
reproducibility lower than
100 ml)
115 38.9
Office B
(two acceptable
manoeuvres, and FEV1
reproducibility between 101
and 150 ml)
59 19.9
Office C
(two acceptable
manoeuvres, and FEV1
reproducibility between 151
and 200 ml)
11 3.7
Office D
(only one acceptable
manoeuvre, or more than
one with FEV1 reproducibility
greater than 200 ml)
0 0
Office F
(no acceptable manoeuvres)
111 37.5
1736 M. Bonavia et al.‘‘screening’’ spirometric tracings in a high percentage of
subjects.
The mean number of telespirometries sent by each GP
was more than 20 during the period of the study. Consid-
ering the high variability of acceptance by GPs, more than
one third of GPs used telespirometry frequently during the
first year of the study (more than 20 tests). To our knowl-
edge, this is the first experience of the use of tele-
spirometry in such a large group of GPs. Up to now
telespirometry has been employed only in very particular
situations.20,21 In comparison with other experiences with
office spirometry,19 in this study telespirometry was
accepted by a large part of the GPs because they were able
to communicate and interact with the pulmonary specialist
in the TCO just a few minutes after performing the test.
This interaction improved the familiarity with the perfor-
mance and the interpretation of the test, leading to an
appreciation that the test was reliable and useful for the
management of the single patient. This fact is particularly
important in countries, such as Italy, where office spirom-
etry is poorly used, unlike in the USA or in north European
countries.14,18 Unfortunately, due to the lack of a persis-
tent access to the TCO and the limitation in the time that
Italian GPs may spend for this activity, the use of tele-
spirometry was interrupted.
The criteria used for the acceptability of telespirometry
were different from those used for laboratory spirometry23
or office spirometry.15 This was due to the lack of full
control by the GP during the performance of thetelespirometry. The Spirotel does not display the flowe
volume curve either during or after performance of the
test, and only information about the characteristics of
single traces (e.g. expiratory time or starting point) was
immediately available to the GPs. However, the GPs did
receive comments on the telespirometry just a few minutes
after performing the test, and were often able to repeat
the test immediately on the same patient, if needed.
Taking into account these factors, associated with the
exploratory aim of the study, the criteria used to evaluate
the acceptability of the telespirometries differed from ATS
and Office criteria. The main difference between our tel-
espirometry and ATS/Office criteria was the expiration
time: we chose 3 s instead of 6 s, as recommended for ATS/
Office spirometry,15,23 because we did not want to exclude
a high percentage of telespirometries, and because the
definition of FEV6 as an important measure in office
spirometry had not been widely accepted at the time the
study was planned.24 However, the 6 s criterium was not
satisfied in 24.3% of the telespirometries defined as showing
good or a partial co-operation. This could have reduced the
sensitivity of the telespirometries to detect airway
obstruction, without loss of specificity. At least two
acceptable traces were obtained in a large proportion of
subjects, while the lack of reproducibility for FVC was
poorly represented. The concordance between tele-
spirometry criteria and Office criteria was better, since
more than 60% of the telespirometric tests defined as
showing good co-operation also achieved level AeC of
acceptability for Office spirometry. Therefore, the
concordance between telespirometry and ATS or Office
criteria was acceptable, and suggests that telespirometry
can be a reasonable surrogate for screening spirometry.
The rate of telespirometric examinations that did not
allow any reasonable information on pulmonary function
was low, showing that in the majority of patients with
suspected chronic airway diseases, telespirometry can
provide GPs with additional informations for the manage-
ment of their patients.
Among telespirometric examinations in which the level of
co-operation was good, the rate of functional abnormalities
was high (about 40% of all acceptable telespirometric tests).
This is dependent on the criteria used by GPs to select
patients for the telespirometry examinations, which
included subjects at risk of asthma or COPD but also subjects
with chronic respiratory symptoms or a previous diagnosis of
asthma or COPD.22 In addition to the classically defined mild
to severe airway obstruction, we also included a category of
mild abnormalities that are not diagnostic of airway
obstruction but that could require further functional evalu-
ation. This category included telespirometries with sus-
pected airway obstruction (normal FEV1 and FEV1/FVC ratio,
but a flow-volume loop morphology suggestive of initial
airway obstruction) and accounted for 3.3% of all tele-
spirometric traces. The presence of ‘‘borderline’’ categories
of possible spirometric abnormalities might increase the
sensitivity of the test, also considering the possibility of
underevaluating airway obstruction due to the limitation in
the end-phase of telespirometry. Among the abnormal tele-
spirometric tests, we also included those with a concomitant
reduction in FEV1 and FVC but with a normal FEV1/FVC ratio,
which accounted for 8.5% of all the examinations. Recent
Telespirometry in general practice 1737recommendations suggest that patients with a concomitant
reduction in FEV1 and FVC and normal FEV1/FVC ratio should
undergo a bronchodilator test.25
In conclusion, this study shows that telespirometry is
well accepted and can be easily performed by a large
number of GPs. A comparison with well-accepted criteria
for quality, as recommended for laboratory spirometry and
office spirometry, shows that telespirometry can reach
acceptable levels of quality for screening spirometry. The
rate of functional abnormalities detected in this large
sample of subjects was appropriate for the selection
criteria. Although neither office spirometry nor tele-
spirometry can be considered a substitute for laboratory
spirometry, telespirometry can be considered as a useful
alternative to office spirometry in improving the manage-
ment of patients with chronic airway diseases by GPs.
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